Radnor Capital Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.85M | Buy |
37,235
+5,320
| +17% | +$475K | 0.54% | 40 |
|
|
2026
Q1 | $2.29M | Hold |
31,915
| – | – | 0.34% | 74 |
|
|
2025
Q4 | $2.53M | Sell |
31,915
-215
| -0.7% | -$16.9K | 0.38% | 72 |
|
|
2025
Q3 | $2.42M | Sell |
32,130
-3,570
| -10% | -$245K | 0.37% | 73 |
|
|
2025
Q2 | $2.46M | Sell |
35,700
-180
| -0.5% | -$11.8K | 0.39% | 67 |
|
|
2025
Q1 | $2.43M | Sell |
35,880
-3,455
| -9% | -$207K | 0.41% | 62 |
|
|
2024
Q4 | $1.77M | Sell |
39,335
-12,479
| -24% | -$700K | 0.3% | 91 |
|
|
2024
Q3 | $3.26M | Buy |
+51,814
| New | +$3.02M | 0.48% | 51 |
|
|
2024
Q2 | – | Sell |
-49,169
| Closed | -$3.92M | – | 183 |
|
|
2024
Q1 | $3.92M | Sell |
49,169
-1,034
| -2% | -$79K | 0.67% | 28 |
|
|
2023
Q4 | $3.96M | Sell |
50,203
-1,218
| -2% | -$86.7K | 0.74% | 22 |
|
|
2023
Q3 | $3.59M | Buy |
+51,421
| New | +$3.64M | 0.71% | 25 |
|
|
2023
Q2 | – | Sell |
-30,992
| Closed | -$2.3M | – | 155 |
|
|
2023
Q1 | $2.3M | Buy |
30,992
+984
| +3% | +$82.5K | 0.61% | 38 |
|
|
2022
Q4 | $3.04M | Buy |
30,008
+1,400
| +5% | +$135K | 0.74% | 24 |
|
|
2022
Q3 | $2.73M | Buy |
28,608
+184
| +0.6% | +$18.2K | 0.79% | 23 |
|
|
2022
Q2 | $2.63M | Buy |
28,424
+775
| +3% | +$75.6K | 0.72% | 28 |
|
|
2022
Q1 | $2.8M | Buy |
27,649
+1,140
| +4% | +$120K | 0.7% | 31 |
|
|
2021
Q4 | $2.73M | Buy |
+26,509
| New | +$2.45M | 0.68% | 34 |
|
|
2021
Q3 | – | Sell |
-22,884
| Closed | -$1.91M | – | 123 |
|
|
2021
Q2 | $1.91M | Sell |
22,884
-130
| -0.6% | -$10.6K | 0.64% | 38 |
|
|
2021
Q1 | $1.73M | Hold |
23,014
| – | – | 0.56% | 49 |
|
|
2020
Q4 | $1.57M | Sell |
23,014
-6,898
| -23% | -$449K | 0.44% | 54 |
|
|
2020
Q3 | $1.75M | Buy |
29,912
+6,561
| +28% | +$408K | 0.59% | 40 |
|
|
2020
Q2 | $1.51M | Buy |
23,351
+400
| +2% | +$25.2K | 0.54% | 44 |
|
|
2020
Q1 | $1.36M | Buy |
22,951
+100
| +0.4% | +$6.68K | 0.56% | 42 |
|
|
2019
Q4 | $1.7M | Buy |
22,851
+220
| +1% | +$15.4K | 0.53% | 42 |
|
|
2019
Q3 | $1.43M | Buy |
22,631
+1,125
| +5% | +$66.7K | 0.47% | 52 |
|
|
2019
Q2 | $1.17M | Buy |
21,506
+50
| +0.2% | +$2.69K | 0.39% | 65 |
|
|
2019
Q1 | $1.16M | Buy |
21,456
+480
| +2% | +$29.6K | 0.38% | 64 |
|
|
2018
Q4 | $1.37M | Hold |
20,976
| – | – | 0.5% | 45 |
|
|
2018
Q3 | $1.65M | Hold |
20,976
| – | – | 0.53% | 43 |
|
|
2018
Q2 | $1.35M | Hold |
20,976
| – | – | 0.5% | 51 |
|
|
2018
Q1 | $1.3M | Hold |
20,976
| – | – | 0.44% | 57 |
|
|
2017
Q4 | $1.52M | Buy |
20,976
+250
| +1% | +$18.2K | 0.49% | 52 |
|
|
2017
Q3 | $1.67M | Hold |
20,726
| – | – | 0.56% | 41 |
|
|
2017
Q2 | $1.67M | Hold |
20,726
| – | – | 0.56% | 41 |
|
|
2017
Q1 | $1.63M | Hold |
20,726
| – | – | 0.55% | 43 |
|
|
2016
Q4 | $1.64M | Buy |
+20,726
| New | +$1.68M | 0.56% | 41 |
|
Other funds holding CVS
Radnor Capital Management's CVS Position: Q2 2026 in Review
Radnor Capital Management increased its CVS Health (CVS) stake by 17% in Q2 2026, buying an estimated $475K and bringing the position to 37,235 shares worth $3.85M. The position accounts for 0.54% of the portfolio, ranked #40.
Radnor Capital Management first reported a position in CVS in Q4 2016 and has held it in 36 quarters since. The position peaked at $3.96M in Q4 2023. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Radnor Capital Management held 37,235 shares of CVS Health worth $3.85M as of Q2 2026.
- Radnor Capital Management bought 5,320 CVS Health shares in Q2 2026, an estimated $475K.
- CVS Health made up 0.54% of Radnor Capital Management's portfolio in Q2 2026, its #40 holding.
- Radnor Capital Management first reported a position in CVS Health in Q4 2016 and has held it in 36 quarters since.
- Radnor Capital Management's CVS Health position peaked at $3.96M in Q4 2023.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Radnor Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.